RFF-19997-02514
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 913 / CA
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-11
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Registered in v-safe
-
2021-03-21
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: GoodFree text: No symptoms, feel good. Thank youMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: I feel greatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-06
- 2021-04-07
- 2021-04-10
- 2021-04-15
- 2021-04-24
- 2021-04-29
- 2021-05-08
- 2021-05-15
- 2021-09-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Free text
Release 6 — day 7, dose 1
Systemic reaction (other): No symptoms, feel good. Thank you
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I feel great
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release